Novavax Inc. (NASDAQ:NVAX) shares are down on Friday, possibly on profit-taking after the stock rallied on Thursday following the company’s announcement of its fourth-quarter and full-year 2025 financial results.
It is worth noting that Novavax has a short interest of 31.41% of its float.
Novavax Q4 Profit Shift
Novavax reported a fourth-quarter earnings shift to a profit of 11 cents, compared to a loss of 51 cents a year ago, with revenue hitting $147 million, a 67% increase year-over-year.
However, the company also projected adjusted total revenue for 2026 between $230 million and $270 million, falling short of the consensus estimate of $381.22 million.
In addition, the company announced it expects Non-GAAP R&D and SG&A expenses of $325 million …